MLKL and cancer: We previously reported that NMRs have lost the ability to induce necroptosis due to loss-of-function mutations in the master regulator genes of necroptosis, RIPK3 and MLKL. This loss likely contributes to carcinogenesis resistance of NMRs by attenuating tissue inflammatory responses associated with cancer promotion [44].